Tamoxifen: Pioneering Medicine in Breast Cancer

Author:   Philipp Y. Maximov ,  Russell E. McDaniel ,  V. Craig Jordan
Publisher:   Springer Basel
Edition:   2013 ed.
ISBN:  

9783034806633


Pages:   199
Publication Date:   06 August 2013
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $527.97 Quantity:  
Add to Cart

Share |

Tamoxifen: Pioneering Medicine in Breast Cancer


Add your own review!

Overview

Full Product Details

Author:   Philipp Y. Maximov ,  Russell E. McDaniel ,  V. Craig Jordan
Publisher:   Springer Basel
Imprint:   Springer Basel
Edition:   2013 ed.
Dimensions:   Width: 15.50cm , Height: 1.80cm , Length: 23.50cm
Weight:   4.616kg
ISBN:  

9783034806633


ISBN 10:   3034806639
Pages:   199
Publication Date:   06 August 2013
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Discovery and Pharmacology of Nonsteroidal Estrogens and Antiestrogens.- Tamoxifen Goes Forward Alone.- Metabolites of Tamoxifen as the Basis of Drug Development.- Adjuvant Therapy – The Breakthrough.- The Wisconsin Story in the 1980’s: Discovery of Target Site Specific Estrogen Action.- Carcinogenesis and Tamoxifen.- Chemoprevention: Cinderella waiting for the ball.- Tamoxifen and Raloxifene head to head: The STAR TRIAL.- Acquired resistance to Tamoxifen: back to the beginning.- The legacy of Tamoxifen.- Appendix: Four decades of discovery in breast cancer research and treatment – an interview with V. Craig Jordan by Marc Poirot.- Selected Awards that Recognize the Contribution of Tamoxifen and Raloxifene to Medicine.

Reviews

From the book reviews: This is a book that had to be written. ... This book should be available in every oncology department. The story will interest clinicians and laboratory scientists alike. It has both historical value and value as a guide that will illuminate the path to successful involvement in cancer research for younger cancer researchers. (R. M. Lowenthal, Inflammopharmacology, Vol. 22 (3), June, 2014) This is a very well-written, readable book for anyone who has an interest in the prevention and treatment of breast cancer, ranging from those involved in drug discovery to those who are treating and taking care of patients with breast cancer. Likewise, anyone who has a loved one who has, or is at high risk for, breast cancer will find this an excellent read. ... It is a well-done and interesting read. (Thomas L. Pazdernik, Doody's Book Reviews, November, 2013)


From the reviews: This is a very well-written, readable book for anyone who has an interest in the prevention and treatment of breast cancer, ranging from those involved in drug discovery to those who are treating and taking care of patients with breast cancer. Likewise, anyone who has a loved one who has, or is at high risk for, breast cancer will find this an excellent read. ... It is a well-done and interesting read. (Thomas L. Pazdernik, Doody's Book Reviews, November, 2013)


From the book reviews: This is a book that had to be written. ... This book should be available in every oncology department. The story will interest clinicians and laboratory scientists alike. It has both historical value and value as a guide that will illuminate the path to successful involvement in cancer research for younger cancer researchers. (R. M. Lowenthal, Inflammopharmacology, Vol. 22 (3), June, 2014) This is a very well-written, readable book for anyone who has an interest in the prevention and treatment of breast cancer, ranging from those involved in drug discovery to those who are treating and taking care of patients with breast cancer. Likewise, anyone who has a loved one who has, or is at high risk for, breast cancer will find this an excellent read. ... It is a well-done and interesting read. (Thomas L. Pazdernik, Doody's Book Reviews, November, 2013)


From the book reviews: “This is a book that had to be written. … This book should be available in every oncology department. The story will interest clinicians and laboratory scientists alike. It has both historical value and value as a guide that will illuminate the path to successful involvement in cancer research for younger cancer researchers.” (R. M. Lowenthal, Inflammopharmacology, Vol. 22 (3), June, 2014) “This is a very well-written, readable book for anyone who has an interest in the prevention and treatment of breast cancer, ranging from those involved in drug discovery to those who are treating and taking care of patients with breast cancer. Likewise, anyone who has a loved one who has, or is at high risk for, breast cancer will find this an excellent read. … It is a well-done and interesting read.” (Thomas L. Pazdernik, Doody’s Book Reviews, November, 2013)


Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List